• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Oct 10, 2024
Discovery & Translation

Science Spotlight: As miRNAs get Nobel Prize, targeting advances continue

BioCentury’s roundup of translational innovation also features Vedanta’s solution to GI infection, Takeda’s exon-skipping delivery tech, and more
Read More
BioCentury | Nov 12, 2015
Distillery Therapeutics

Therapeutics: MicroRNA-10b (miR-10b)

Read More
BioCentury | Apr 5, 2010
Clinical News

Regulus preclinical data

Read More
BioCentury | Apr 1, 2010
Distillery Therapeutics

Indication: Cancer

Read More
Items per page:
1 - 4 of 4
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa